| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 7.35 CAD | 0.03 (+0.41%) | 5.67 - 7.35 | -- |
Market data as of 12:00AM 05/17/13. Quotes are delayed by at least 15 min.
The primary investment objective of the International Equity Value Corporate Class is to provide long-term capital appreciation primarily through investment in a diversified portfolio of equity and equity-related securities of international issuers which are believed to be undervalued relative to their perceived growth potential. Equity-related securities include convertible preferred shares, convertible debt obligations and warrants. This Fund also may invest in other mutual funds. The portfolio advisors will not invest in Canadian or US issuers. Any change to the investment objectives must be approved by a majority of the votes cast by shareholders at a meeting called to consider the change.
| Total Return | -6.46% |
|---|---|
| Yield (Trailing 12 Mo.) | 0.00% |
| Expense Ratio | -- |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | $500.00 |
| Management Tenure | 4 Years |
| Fund Inception | 10/22/2007 |
| Timeframe | MUTUAL:CIG17664 | S&P 500 | International Equity |
|---|---|---|---|
| 1 Month | 0.73% | 1.93% | 2.84% |
| 3 Month | 7.94% | 7.18% | 3.99% |
| Year-to-Date | 7.94% | 12.74% | 8.53% |
| 1 Year | 8.62% | 16.89% | 17.55% |
| 3 Year | 2.66% | 12.80% | 5.12% |
| 5 Year | -4.71% | 5.21% | -2.17% |
| 10 Year | -- | 7.88% | 4.33% |
| Since Inception | -6.46% | 10.38% | -- |
| Basic Materials | 7.78% | |
|---|---|---|
| Consumer Cyclical | 6.18% | |
| Financial Services | 16.53% | |
| Real Estate | 1.36% | |
| Consumer Defensive | 18.98% | |
| Healthcare | 11.87% | |
| Utilities | 1.50% | |
| Communication Services | 4.95% | |
| Energy | 11.81% | |
| Industrials | 15.54% | |
| Technology | 3.50% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | -- | 11.99 | 11.99 | ||
| Bond | -- | 0.00 | 0.00 | ||
| Other | -- | 0.00 | 0.00 | ||
| Foreign Stock | -- | 81.92 | 81.92 | ||
| Foreign Bond | -- | 0.00 | 0.00 | ||
| Total | -- | 93.91 | 93.91 | ||
| Cash | -- | 6.09 | 6.09 | ||
| Total Net Assets | $196.98M |
|---|---|
| Total Stock Holdings | 55 |
| Total Bond Holdings | 0 |
| Company | YTD Return | % of Assets |
|---|---|---|
| Roche Holding AG | 16.70% | 2.97% |
| Heineken N.V. | -- | 2.83% |
| GlaxoSmithKline PLC | 5.86% | 2.76% |
| WSH | 18.16% | 2.74% |
| Novartis AG | 12.97% | 2.63% |
| COV | 17.23% | 2.58% |
| Nestle SA | 11.35% | 2.53% |
| BP PLC ADR | 2.19% | 2.48% |
| Bank of Yokohama | -- | 2.43% |
| Vodafone Group PLC ADR | 12.50% | 2.42% |
| Valuation | MUTUAL:CIG17664 | Category Range |
|---|---|---|
| Price/Earnings | 12.10 | |
| Price/Book | 1.38 | |
| Price/Sales | 0.80 | |
| Price/Cash Flow | 8.96 | |
| Dividend Yield | 2.64 | |
| LT Earnings | 8.63 | |
| Historical Earnings | 10.97 | |
| Sales Growth | -0.41 | |
| Cash-Flow Growth | -7.9 | |
| Book-Value Growth | 2.07 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Low | |
| Return | Below Avg |
| Pretax Return | 2.66% |
|---|---|
| Tax-adjusted Return | 2.63% |
| Tax Cost Ratio | 0.03% |
| Potential Cap Gains | -- |
